FDA Inspection 824130 — AHN Center for Reproductive Medicine

AHN Center for Reproductive Medicine — FEI 3004571445

The FDA completed an inspection of AHN Center for Reproductive Medicine on April 2, 2013 in Pittsburgh, PA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 2, 2013
Fiscal Year
2013
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Pittsburgh, PA (United States)

Citations

IDCFRDescription
1221321 CFR 1271.47(a)Testing, screening, donor eligibility procedures
1222321 CFR 1271.47(b)Review and approval of procedures